| Literature DB >> 34066752 |
Daphne S Blount1, Daniel J McDonough2, Zan Gao2.
Abstract
This systematic review synthesized all randomized controlled trials (RCTs) and controlled trials examining the effects of wearable health technology-based physical activity interventions on physiological, cognitive, and emotional outcomes in breast cancer survivors (BCS). We searched NCBI, Academic Search Premier, EMBASE, Web of Science, PubMed, and Medline from inception to March 2021. We included studies which: (1) were RCTs or controlled trials ≥8 weeks in duration; (2) were peer-reviewed and published in English; (3) sampled BCS in full remission and had not received treatment for at least six months; (4) utilized wearable health technology (e.g., Fitbit, Garmin xGC30); and (5) examined physiological, emotional, and/or cognitive outcomes. Sixty-six studies were identified and 14 were included in the review. Most of the observed effects were statistically significant and those which employed multi-component interventions generally yielded greater effects. Overall, the use of wearable health technology reduced sedentary behavior and increased moderate-to-vigorous intensity physical activity. Further, increased moderate-to-vigorous intensity physical activity was observed to be associated with increased perceived cognition and higher cognitive performance. Multiple studies also observed significant improvements in attitude, worry, and anxiety. Overall, findings suggested wearable health technology-based physical activity interventions to be effective for improving physical activity, attitude, and cognitive functions and for reducing sedentary behavior, anxiety, and worry in BCS.Entities:
Keywords: activity tracker; exercise; health promotion; randomized controlled trial; sedentary behavior
Year: 2021 PMID: 34066752 PMCID: PMC8125804 DOI: 10.3390/jcm10092015
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Flowchart of literature search and screening. Note, * reasons for exclusions included ineligible age, ineligible exposure, ineligible analysis, ** reasons for exclusion included ineligible outcomes and lack of means/standard deviations.
Characteristics of individual studies.
| Title | Authors (Date) | Purpose and Intervention(s) | Sample and Setting | Design/Method | Findings |
|---|---|---|---|---|---|
| Effectiveness of Combined Smartwatch and Social Media Intervention on BCS Health Outcomes: A 10-Week Pilot Randomized Trial | Pope, Zeng, Zhang, Lee, Gao | Goal: To determine effectiveness of combined smartwatch and social media-based intervention on BCS health outcomes. | 30 middle aged BCS participants. Control group ( | 10-week 2 arm randomized controlled trial. Outcomes measured at baseline and after 10-week trial. Physiological, psychosocial, and quality of life (QoL) factors measured by validated instruments. Physical activity (PA), energy expenditure (EE), and steps measured by ActiGraph GT3X+ and Polar M400. | Both groups had slightly increased daily LPA, ZMVPA, EE, and steps but there was no significant difference between groups. intervention group demonstrated improved sleep quality and reduced social life limitations. There were significant group differences for social support and barriers, control group improved in both areas, intervention group had decreased social support. Several BCS found the Polar M400 difficult to use. |
| Living Well after Breast Cancer: Changes in Objectively Measured Physical Activity in a Weight Loss Trial | Reeves, Winkler, McCarthy, et al. (2012) [ | Goal: To determine if weight loss and PA are effective in improving BCS outcomes. | 90 overweight/obese women diagnosed with BC 9–15 months prior to study. Control group ( | Participants are from a convenience sample recruited from Queensland Cancer Registry. 6 month randomized controlled trial. GT3X+ ActiGraph measured PA at baseline and after 6-month intervention. Freedson cut-offs determined total MVPA per day. Daily lifestyle and walking/running MVPA identified using Crouter’s two-step regression. Linear mixed models used to examine intervention effects (only used for | Both groups experienced significant increase in MVPA after trial, increase in MVPA was greater in intervention group than control group. Intervention significantly increased walking/running MVPA but not lifestyle MVPA. |
| A Randomized Controlled Trial of Wearable Technology-Based Intervention for Increasing Moderate to Vigorous Physical Activity and Reducing Sedentary Behavior in BCS: The ACTIVATE Trial | Lynch, Nguyen, Moore, Reeves, Rosenberg, Boyle, Vallance, Milton, Friedenreich, English. | Goal: Use active smartwatch and other interventions to increase MVPA and reduce sedentary behavior in BCS. | 80 inactive, postmenopausal BCS who had completed primary breast cancer treatment. Control group ( | 12-week randomized controlled trial, GT3X+ ActiGraph and ActivPAL were used to measure physiological outcomes at baseline and after 12 weeks. Outcomes measured include PA and sitting and standing time. See Lynch et al. ACTIVATE methods paper for more information. | Significant change for both groups in MVPA with intervention group having greater MVPA increase. Significant change occurred in sitting time and prolonged bouts of sitting observed in both groups with intervention group having greater change from baseline. |
| Maintenance of Physical Activity and Sedentary behavior Change, and Physical Activity and Sedentary Behavior Change After an Abridged Intervention: Secondary Outcomes from the ACTIVATE Trial | Lynch, Nguyen, Moore, Reeves, Rosenberg, Boyle, Milton, Friedenreich, Vallance, English | Goal: Determine if intervention from ACTIVATE trial had long lasting effects on MVPA and sedentary behavior after trial completion. | Participants from original trial, 80 inactive, postmenopausal BCS who had completed primary breast cancer treatment. Control group ( | MVPA and sedentary behavior were measured and compared from conclusion of 12-week trial to 12 weeks post-trial. MVPA and sedentary behavior were measured using ActiGraph and ActivPAL (worn for 7 days). Both groups received Garmin Vivofit 2 to use during post-intervention time. Linear mixed model with random effects were used to examine within-group changes in MVPA and sitting time. | 12 weeks post-trial, women in intervention group had maintained increased levels of MVPA). At 12 weeks post-trial, sitting time had increased slightly but did not return to baseline. Control group when using smartwatch increased MVPA and reduced sitting time over 12-week post-intervention period. |
| Effects of The BEAT Cancer Physical Activity Behavior Change Intervention on Physical Activity, Aerobic Fitness, and Quality of Life in BCS: a Multicenter Randomized Controlled Trial | Rogers, Courneya, Anton, et al. (2015) [ | Goal: Determine if BEAT Cancer intervention can change BCS PA, aerobic fitness, and QoL factors. | 222 post-primary treatment BCS. Control group ( | 3-month randomized controlled trial. Assessments measured at baseline, after 3-month intervention, and 3 months post-intervention. Baseline measurements made with use GT3X+ accelerometer and self-reported PA submaximal treadmill test, and QoL assessment as measurements. Adjusted linear mixed-model analysis used. | BEAT Cancer at 3 mo. showed significant increase in weekly minutes of MVPA (accelerometer measured) and self-reported exercise. Significant increase remained at 6 mo. only for self-reported PA. BEAT Cancer groups were significantly more likely to meet PA suggested standards at both the 3- and 6-month mark. BEAT Cancer significantly improved fitness at mo. 6 and QoL at 3 and 6 mo. BEAT Cancer intervention significantly improved PA, fitness, and QoL continuing up to 3 mo. post-intervention |
| Mediators of a Physical Activity Intervention on Cognition in Breast Cancer Survivors: Evidence from a Randomized Controlled Trial | Hartman, Weiner, Nelson, et al. (2019) [ | Goal: Determine the mechanism through which PA influences BCS cognition. | 87 sedentary BCS. Intervention group ( | 12-week randomized controlled trial. Outcomes measured include processing speed (NIH), self-reported cognition (PROMIS), physiological and psychological function (PROMIS), plasma biomarkers. Measurements collected at baseline and after 12-week intervention. Statistical methods include linear mixed-effect model and bootstrapping. See BEAT Cancer methods paper for more information. | Exercise arm group showed significant improvement in physical functioning and reduced anxiety. Anxiety significantly mediated intervention’s effect on cognitive abilities. Physical activity does not act as a mediator. No biomarkers had changes relevant to the study. Cognitive ability/processing speed did not have any mediated effect from PA. |
| Patterns of Fitbit Use and Activity Levels Throughout a Physical Activity Intervention: Exploratory Analysis from a Randomized Controlled Trial | Hartman, Nelson, Weiner, (2018) [ | Goal: Explore the relationship between Fitbit activity trackers and success with PA interventions based on ActiGraph and determine if these interventions are sustainable. | 87 female BCS randomized into intervention and control arm groups. Control group ( | 12-week randomized controlled trial. Data collected at baseline and at week 12. Fitbit One was worn daily to collect the metabolic equivalent of tasks (MET) on a per-minute basis all day. ActiGraph GT3X+ worn by both groups for 7 days at beginning and end to create baseline and 12-week assessments which measured the quantity of MVPA. Participants self-reported how frequently they checked their Fitbits using 8-point Likert scale. Mixed effects ANOVA used and linear mixed effects model. | Adherence to wearing Fitbit was high (~88%). Increased adherence to wearing Fitbit associated with increased MVPA (as measured by ActiGraph). 68% participants reported looking at tracker or website 1+ times per day. Changes in MVPA were significant with the wearable fitness trackers but not significant when checking app or website. More frequent checking of Fitbit associated to smaller changes in MVPA. |
| Breast Cancer Survivors Reduce Accelerometer-measured Sedentary Time in an Exercise Intervention | Weiner, Takemoto, Godbol, et al. (2019) [ | Goal: Assess whether tech-based PA interventions can significantly increase MVPA. | 87 BCS that were insufficiently active, were diagnosed less than 5 years prior to study enrollment, and had completed treatment. Control arm ( | 12-week randomized controlled trial. Outcomes measured were total sedentary behavior, LPA and MVPA. Outcomes were measured at baseline and after 12-week intervention using ActiGraph GT3X+ accelerometer. Linear mixed-effect models tested effects of intervention on sedentary, LPA and MVPA, change in sedentary vs. change in MVPA, and potential relationships between outcomes and sedentary behavior. | Exercise arm had significant reduction in sedentary behavior compared to control arm. Larger MVPA increase associated to larger sedentary decrease. Women further from surgery had significantly greater sedentary reductions. No significant changes in LPA. |
| Randomized Controlled Trial of Increasing Physical Activity on Objectively Measured and Self-reported Cognitive Functioning among Breast Cancer Survivors: The Memory and Motion Study | Hartman, Nelson, Meyers, Natarajan, Sears, Palmer, Weiner, Parker, Patterson (2018) [ | Goal: Determine if intervention in PA would benefit cognition in BCS as compared to control group. | 87 BCS, post-BC treatment, diagnosed at least 5 years prior to study, experiencing self-reported sedentary lifestyle or fogginess/depletion of cognitive function. Intervention group ( | 12-week randomized controlled trial. Outcomes measured at baseline and at 12 weeks. ActiGraph measured PA. Objective cognitive performance was measured with the NIH Cognitive Toolbox. Self-reported cognition collected using Patient-Reported Outcomes Measurement Information scales. Linear mixed-effects regression model tested intervention and cognition change. | Processing speed showed significant improvement in exercise arm. Improvement in self-reported cognition between groups was not statistically significant but were large enough to show potential differences. Participants 2+ years post-surgery had significantly greater improvement in processing speed than participants less than 2 years post-treatment. Within the intervention group, those who had greater increased physical activity showed significant improvements in both objective and self-reported cognition. |
| Preventing Weight Gain in African American Breast Cancer Survivors Using Smart Scales and Activity Trackers: A Randomized Controlled Pilot Study | Valle, Deal, Tate | Goal: Determine feasibility of using smart scales and activity trackers to prevent weight gain in African American BCS. | 35 AA BCS, diagnosed with stage 1–3 BC within the last 10 years, who have completed treatment, have no active cancer, and have a BMI of 20–45 kg/m3. There were two intervention groups and one control group. Group one ( | 6 month randomized controlled trial. Online and in-person assessments were taken at baseline, 3 month, and 6-month mark. Throughout the trial, the activity tracker and scale objectively measured PA and weight. | Average weight loss at 6 months was −0.9% in intervention + tracker group. Average weight loss at 6 mo. was −0.2% in intervention only group. Control group gained on average +0.2%. Adherence rate to trial was very high. Daily self-weighing was perceived as positive by both intervention groups and 100% of participants recommend program to other BCS. |
| A Qualitative Evaluation of Breast Cancer Survivors’ Acceptance of and Preferences for Consumer Wearable Technology Activity Tracker | Nguyen, Hadgraft, Moore, Reeves, Rosenberg, Lynch, Reeves, Lynch | Goal: Assess the usability of wearable activity trackers among postmenopausal BCS. | 14 postmenopausal BCS women, stage 1–3 BC, post treatment completion at least 6 months prior. | Series of multiple 2-week randomized controlled trials. Women tested two or three randomly assigned trackers. The device was worn for 2 weeks with a 1-week break between wearing the next device. Each tracker had to count steps and notify the participants via a notification if they were sedentary for an extended period. Focus groups were held to interview women on perceptions and experience with each tracker. Thoughts were transcribed and grouped into themes and later analyzed statistically. | 5 primary themes |
| Activity Tracker to Prescribe Various Exercise Intensities in Breast Cancer Survivors | McNeil, Brenner, Stone, et al. (2019) [ | Goal: Determine if activity tracker can be used to effectively prescribe various PA intensities and increase PA, reduce sedentary time, improve health outcomes. | 45 BCS (survivors of stage 1–3 breast cancer) who are no longer in treatment (excluding hormone therapy), who currently take fewer than 10,000 steps per day. Intervention group one ( | 12-week randomized controlled trial. Measurements recorded at baseline, 12 weeks, and 24 weeks taken with ActiGraph GT3X+ trackers. Outcomes measured were sedentary time, health-related fitness, and patient-reported outcomes. Intervention groups received Polar A360 trackers. Linear mixed model used to adjust data | In high intensity group, MVPA significantly increased. In low intensity group, sedentary time significantly decreased. VO2 Max was also significantly increased at 12-week mark for both experiment groups, with the high intensity group seeing a greater increase. Changes in PA and VO2 Max were sustained at 24-week follow up but were no longer significant. |
Assessment of risk of bias of individual studies.
| Article | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| Hartman et al. [ | + | + | − | + | + | + | NA | + | − | 6 * |
| Hartman et al. [ | + | + | + | + | + | + | + | − | − | 7 * |
| Hartman et al. [ | + | + | − | + | + | + | − | + | − | 6 * |
| Lynch et al. [ | + | + | − | + | + | + | + | + | − | 7 * |
| Lynch et al. [ | + | + | − | + | + | + | + | − | − | 6 * |
| McNeil et al. [ | + | + | − | + | + | NA | NA | NA | + | 5 * |
| Nguyen et al. [ | + | − | + | NA | NA | − | + | − | − | 3 |
| Pope et al. [ | + | + | − | + | + | − | NA | − | − | 4 |
| Reeves et al. [ | + | + | − | + | + | NA | NA | − | − | 4 |
| Rogers et al. [ | + | + | − | + | + | + | + | + | − | 7 * |
| Valle et al. [ | + | + | − | + | + | + | + | − | − | 6 * |
| Weiner et al. [ | + | + | + | + | + | + | NA | − | − | 6 * |
Note. Item numbers indicate the following quality: 1 = randomization of subjects, 2 = presence of a control in study, 3 = health wearable tracker technology was used as isolated intervention method, 4 = outcome variables were measured before and after intervention, 5 = baseline measurement was taken of key outcome variables, 6 = study retention was described and at least 70%, 7 = intervention adherence was described and at least 70%, 8 = power analysis was conducted to determine appropriate sample size, 9 = participants were followed up with for a minimum of 6 months post-intervention. Scores indicated: “+” = presence of attribute, “−” = absence of attribute, “NA” = not applicable to study. A * denotes a paper at or above the median score of 5 for bias-prevention methods.